JITC at SITC 2017

Journal for ImmunoTherapy of Cancer Editor-in-Chief: Professor Pedro Romero     SUBMIT MANUSCRIPT  |  EDITORIAL BOARD  |  SUBMISSION GUIDELINES  |  ARTICLE ALERTS

Dear Prof CERASALE MORTEO, This year Journal for ImmunoTherapy of Cancer will once again be exhibiting at the Society for Immunotherapy of Cancer (SITC) Annual Meeting. Find us at the SITC booth where you can learn more about how the journal’s publishing policies empower authors and their research—a tangible effort to incentivize open collaboration. Click here for featured articles related to the conference. Highlighted Articles CLINICAL TRIALS MONITOR Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy   Hasan Rehman et al. Abstract   |  Full text   |  PDF POSITION ARTICLE AND GUIDELINES Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma   Brian I. Rini et al. Abstract   |  Full text   |  PDF COMMENTARY Cancer immunotherapy trials: leading a paradigm shift in drug development   Leisha A. Emens et al. Full text   |  PDF Journal Scope Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications. JITC welcomes submissions to the following sections: • Basic Tumor Immunology - edited by Cornelis J. Melief • Case Reports - edited by Alfred Zippelius • Clinical Trials Monitor - edited by Leisha A. Emens • Clinical/Translational Cancer Immunotherapy - edited by James L. Gulley • Commentary/Editorials - edited by Christian Capitini • Guidelines and Consensus Statements - edited by Robert L. Ferris • Immunotherapy Biomarkers - edited by Lisa H. Butterfield • Reviews - edited by Thomas F. Gajewski and Per Thor Straten Reasons to Publish with Us • The official journal of the Society for Immunotherapy of Cancer (SITC) • Free article processing charges for SITC members • Distributed to over 15,000 individuals in the cancer treatment space and downloaded more than 800,000 times in 2015 Publish With Us Register to receive the latest articles, straight to your inbox. Best wishes, Journal for ImmunoTherapy of Cancer OFFICIAL JOURNAL OF THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) Follow BioMed Central:    How to ensure BioMed Central's emails reach your inbox You have received this message in a belief that it would be of interest. If you would not like to receive any further messages from BioMed Central, please visit our general unsubscribe page. For further information or enquiries please contact Customer Services at:info@biomedcentral.com. BioMed Central Ltd 236 Gray's Inn Road, London, WC1X 8HB, United Kingdom. Part of Springer Nature. Privacy Policy BMC40963